c="Fabry disease" 1:3 1:4||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="Fabry disease" 2:0 2:1||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="alpha-galactosidase A" 2:2 2:3||t="medication"||cui="C0002268"||tot="Alpha-galactosidase"||ns="-734"
c="this disease" 2:34 2:35||t="problem"||cui="C0012634"||tot="Disease"||ns="-1000"
c="beta-galactosidase" 2:52 2:52||t="medication"||cui="C0005220"||tot="beta-Galactosidase"||ns="-1000"
c="second DBS assay" 2:76 2:78||t="test"||cui="C0005507"||tot="Biological Assay"||ns="-804"
c="GLA gene mutations" 2:118 2:120||t="test"||cui="C1439334"||tot="GLA gene"||ns="-901"
c="Fabry disease" 2:165 2:166||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="therapeutic intervention" 2:199 2:200||t="treatment"||cui="C0808232"||tot="Therapeutic Intervention"||ns="-1000"
